icon 11630 SW 97 Street, Miami, Florida 33176, US

Tag: GBM

KAZIA RECOGNISES GBM AWARENESS DAY 2022 AS IT EXPANDS CLINICAL TRIAL ACTIVITY IN EUROPE AND US

Press Release

Sydney, 20 July 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is lending its support to Glioblastoma (GBM) Awareness Day 2022 and remains firmly focused on developing a treatment that may help improve the […]

Read More>>